Cafepharma Today

March 26 2025 - Trump turbulence stalls large pharma and biotech deals, bankers say
Trump turbulence stalls large pharma and biotech deals, bankers say
Bayer acquires rights in Puhe BioPharma cancer drug candidate
Wave's DMD drug remains on track in 48-week data ahead of FDA push next year
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA’s return-to-office chaos, probationary workers reinstated, and demotion fears
RAPS.org
Monday, March 17, 2025 - 10:18pm
tags:
FDA, White Oak
Advanced Biomed IPO Raises $6.56M Towards Liquid Biopsy Testing
Xtalks
Monday, March 17, 2025 - 10:15pm
tags:
Advanced Biomed, IPO, liquid biopsy
Incyte Loses 9% As Skin Disease Drug Looks 'Viable, But Not Competitive'
Investors Business Daily
Monday, March 17, 2025 - 10:14pm
tags:
Incyte, povorcitinib, clinical trials, hidradenitis suppurativa
AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite Merck-Halozyme patent drama
Fierce Pharma
Monday, March 17, 2025 - 10:11pm
tags:
AstraZeneca, Alteogen, oncology, cancer, subcutaneous drug delivery
AstraZeneca makes potential $1B cell therapy play in EsoBiotec buy
BioSpace
Monday, March 17, 2025 - 11:24am
tags:
AstraZeneca, EsoBiotec, cell therapy, M&A
OPKO and Entera Bio partner on oral obesity treatment
Investing.com
Monday, March 17, 2025 - 11:22am
tags:
OPKO Health, Entera Bio, obesity
Ireland could lose pharma tax to US after Trump accusations, experts warn
The Guardian, UK
Monday, March 17, 2025 - 11:16am
tags:
Ireland, Donald Trump, drug manufacturing
Otsuka's Taiho pays $400M for Swiss partner to 'turbocharge' 3 ADCs to clinic
Fierce Biotech
Monday, March 17, 2025 - 11:09am
tags:
Otsuka, Taiho Pharmaceutical, M&A, Araris Biotech
Incyte posts phase 3 skin condition wins but details disappoint, sinking stock
Fierce Biotech
Monday, March 17, 2025 - 11:05am
tags:
Incyte, clinical trials, povorcitinib
Scholar Rock SMA drug shows muscle function benefit
Clinical Trials Arena
Monday, March 17, 2025 - 10:59am
tags:
Scholar Rock, spinal muscular atrophy, SMA, apitegromab, clinical trials
AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer
Clinical Trials Arena
Monday, March 17, 2025 - 10:58am
tags:
AbbVie, platinum-resistant ovarian cancer, ovarian cancer, Elahere, clinical trials
Novartis CEO says it is watching US reciprocal tariff policy 'very carefully'
MSN/Reuters
Monday, March 17, 2025 - 10:14am
tags:
Novartis, Pharma CEOs, Vas Narasimhan, tariffs, importation
Drug developers ‘haven’t even scratched the surface’ of what radiopharma can do
Pharma Voice
Monday, March 17, 2025 - 10:13am
tags:
radiopharmaceuticals, oncology, Ratio Therapeutics, Radiopharm Theranostics, Aktis Oncology, Perspective
Trump and RFK promised to ban D2C pharma advertising. Pharma is ready for a fight.
Pharmaphorum
Monday, March 17, 2025 - 10:07am
tags:
DTC advertising, Donald Trump, Robert F Kennedy Jr.
Latigo raises $150m for non-opioid painkiller push
Pharmaphorum
Monday, March 17, 2025 - 10:06am
tags:
Latigo, funding, non-opioid pain treatments, Vertex Pharmaceuticals, Journavx
Biotech Maxion Therapeutics secures $72M Series A
Tech.eu
Monday, March 17, 2025 - 10:05am
tags:
Maxion Therapeutics, funding, chronic pain, autoimmune disease, cardiovascular disease
Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
Stock Titan
Sunday, March 16, 2025 - 9:59pm
tags:
Sanofi, vaccines, Flu, flu vaccines
Johns Hopkins Will Terminate More Than 2,000 Employees, Igniting Public Health And Security Concerns
Forbes
Sunday, March 16, 2025 - 9:56pm
tags:
Johns Hopkins, layoffs, Public Health, NIH
UK lifts drug rebate rate as pharma industry decries ‘fundamentally broken’ market
Fierce Pharma
Sunday, March 16, 2025 - 9:53pm
tags:
UK, drug rebates, ABPI
Labcorp is buying Bioreference health’s cancer testing business for $192m
MedCity News
Sunday, March 16, 2025 - 9:52pm
tags:
Medtech, diagnostics, M&A, LabCorp, BioReference Labs, cancer

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

Starving Cancer Cells Where They Live
In the Pipeline
Informa Connect’s Life Sciences Pricing & Contracting USA
Drug Channels
Evolving the Ability to Evolve
In the Pipeline
Metamorphine, An Unwelcome Product
In the Pipeline
The End of the Blockbuster Era: Unlocking Growth with Direct-to-Patient Commercialization
Drug Channels
A New Type of Antifungal
In the Pipeline
The Continuing Crisis, Part IX: Inside the NIH Now
In the Pipeline
NOW AVAILABLE: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels
How Much Does Math Help Chemistry Students?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.